About PAIGE
PAIGE is a Healthcare company based in New York (United States) founded in 2018 by David Klimstra and Thomas Fuchs, and was acquired by Tempus in August 2025. AI-enabled tools for computational pathology and cancer diagnostics are provided. It operates in the Healthcare and Technology sectors. PAIGE has raised $241 million across 8 funding rounds from investors including Microsoft, Goldman Sachs and Tempus. Its chief executive, as recorded, is Razik Yousfi. Its website paige.ai draws about 21 thousand monthly visits. PAIGE offers products and services including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its legal entity is PAIGE AI, INC. Its competitors include PathAI, Viz.ai and Deepcell; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.
Products & Services of PAIGE
PAIGE offers a comprehensive portfolio of products and services, including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.
AI for detecting and diagnosing prostate cancer on tissue images
AI applications for breast cancer identification and classification
AI tools for gastrointestinal cancer detection and classification
Multi-modal tool to streamline pathology workflows and diagnostics
Funding Insights of PAIGE
PAIGE has successfully raised a total of $241M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $19.5 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $241M
- Total Rounds 8
- Last Round Series C β $19.5M
- First Round $25M
(Feb 2018)
- Investors Count 11
All 8 funding rounds of PAIGE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $19.5M | Series C | β | Microsoft | β |
| Mar 2021 | $25M | Series C | β | KKR, Casdin Capital | |
| Jan 2021 | $100M | Series C | β | Johnson & Johnson Innovation – JJDC, Casdin Capital | β |
| Jul 2020 | $20M | Series B | β | Goldman Sachs | |
| Apr 2020 | $5M | Series B | β | Goldman Sachs | β |
| Dec 2019 | $45M | Series B | β | Healthcare Ventures | |
| Apr 2019 | $1.5M | Seed | β | β | |
| Feb 2018 | $25M | Series A | β | Jim Breyer | β |
12 investors in total: 10 institutional and 2 angel.
Investors in PAIGE
PAIGE has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, Goldman Sachs and Tempus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
| hcven.com | ||||
Venture capital firm | breyercapital.com | Menlo Park, United States | ||
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Venture capital is provided to biomedical technology startups. | cataliocapital.com | New York, United States | ||
Venture capital funding is provided to early-stage startups. | geekdomfund.com | |||
Microsoft is recognized for software, hardware, and gaming solutions. | 1975 | microsoft.com | Redmond, United States | |
KT Kenan Turnacioglu | Angel investor and entrepreneur, co-founder of Gram Games, active in tech startups | unknown_61c8951b6dde4467a |
Investor details for PAIGE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PAIGE
48 people are tracked at PAIGE (14 in leadership, 18 in board & advisors, 16 in team).
| Name | Role | Group |
|---|---|---|
David Klimstra | Co-Founder | Leadership |
Thomas Fuchs | Co-Founder | Leadership |
Razik Yousfi | CEO & CTO | Leadership |
Jason Lewis | Sales Director | Leadership |
Alexis Ahiekpor-Dravi | Director Of AI Engineering | Leadership |
Jennifer Andreasson | Director of Technical Operations | Leadership |
David S. Klimstra | Founder, Chief Scientist | Leadership |
Gerard Slootweg | VP of Sales | Leadership |
Juan Retamero | Medical Vice President | Leadership |
Peter Hamilton | Chief Operational Officer | Leadership |
Djamilia Dierov, MPH | Vice President Of Business Development & Partnerships | Leadership |
Caitlin McWilliams | VP Of Finance And Corporate Development | Leadership |
Chris Kanan | Director, AI Scientist | Leadership |
Mike Kramer | VP of Pathology & Medical Services, Quest Diagnostics | Leadership |
Kenan Turnacioglu | Board Chairman | Board & advisors |
David Rimm | Member, Advisory Board | Board & advisors |
Eli Casdin | Board Member | Board & advisors |
John Iafrate | Member, Advisory Board | Board & advisors |
Asish K. Xavier | Member Board Of Directors | Board & advisors |
Jefrey C. Lightcap | Board Member | Board & advisors |
28 more people are available in the full profile.
Complete people profiles for PAIGE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PAIGE
4 dated milestones of PAIGE across 7 years, from founding to its latest funding, stage changes and deals.
- Founded PAIGE is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series C, of $19.5M.
- Exit Acquired by Tempus.
Competitors of PAIGE
PAIGE has 3 listed competitors in our database, 3 of them funded. They include PathAI, Viz.ai and Deepcell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research |
Detailed competitors of PAIGE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PAIGE
The website of PAIGE (paige.ai) receives about 20.8K visits a month.
- Monthly visits20.8K
▼ 8.1% vs previous month
Websites whose visitors overlap most with PAIGE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cardmaillouisville-my.sharepoint.com | cardmaillouisville-my.sharepoint.com | 100% | β | ||
| pageai.co | 50% | 9.4K | #2,629,693 | View details |
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as PAIGE (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paige
Complete news archive for PAIGE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PAIGE
PAIGE was founded in 2018.
PAIGE is headquartered in New York, United States. It is registered at New York, New York, United States.
Razik Yousfi is the CEO of PAIGE, as recorded in our data.
PAIGE is a funded company, having raised a total of $241M across 8 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Feb 2018.
Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.
PAIGE offers Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.
PAIGE has 12 investors. Key investors include Microsoft, Goldman Sachs, Tempus, KKR, and Johnson & Johnson Innovation β JJDC.
PAIGE operates through Paige Ai, Inc.
Yes. PAIGE was acquired by Tempus in August 2025.

